Developer docs
API playgroundTry for free, no card

Search company profiles

Wörwag Pharma

Full company profile

uuid000nigr

Namestring
Wörwag Pharma
Legal namestring
Wörwag Pharma GmbH & Co. KG
Company typeenum
Private
Founded yearint
1971
Descriptiontext

Wörwag Pharma is a family-owned German pharmaceutical company founded in 1971 in Stuttgart, headquartered in Böblingen, and operating as a GmbH & Co. KG. It specializes in biofactor products — vitamins, minerals, trace elements, and selected herbal actives — for the prevention and treatment of lifestyle-related and metabolic diseases, organized around four therapeutic areas: diabetic comorbidities (notably diabetic polyneuropathy and fatty liver), nervous system health, immune support, and musculoskeletal health. The portfolio spans prescription medicines (e.g., Thiogamma 600 oral, benfotiamine formulations), OTC products (B12 Ankermann, Milgamma, Zinkorot 25, magnerot, Vitagamma), and dietary supplements (ReDia, Lagosa Triplex), with proprietary high-bioavailability formulations such as benfotiamine developed by the founder and the patented ReDia HPMC fiber product. Products are sold in 35+ countries, frequently as category leaders, with deepest historic roots in Central and Eastern Europe and accelerating growth in Asia (Vietnam, Thailand, Philippines, Kazakhstan) and South America (Peru).

The company generates revenue through pharmaceutical product sales distributed via retail pharmacies, pharmacy chains, and pharmaceutical wholesalers, supported by a field sales force that engages doctors and pharmacists, an HCP portal (Fachkreise) with CME-certified content, and a global Health Academy webinar series launched in 2026. Direct pharmacy ordering is enabled through the PharmaMall e-commerce storefront and the MSV3 electronic data interchange, alongside traditional phone/email channels. Wörwag has built vertically integrated manufacturing through the 2021 acquisition of Sensilab (now Wörwag Pharma Operations in Łódź, Poland) and the 2023 acquisition of Mauermann Arzneimittel (now Wörwag Pharma Production in Pöcking, Germany), which together accounted for 42% of packages sold and 33% of the product portfolio from own production in 2025. Family ownership (Wörwag family), a managing-director governance model with Jochen Schlindwein as CEO and Gerhard Mayer as CFO, and a ~1,500-employee workforce across 25+ nationalities support a private, founder-anchored operating model.

Short descriptiontext

Wörwag Pharma is a family-owned German pharmaceutical company that develops and sells biofactor products (vitamins, minerals, trace elements) for prevention and treatment of lifestyle diseases, with a focus on diabetic comorbidities, nervous system, immune, and musculoskeletal health across 35+ markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersBöblingen, Germany
HQ citystring
Böblingen
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical products, biofactor supplements, OTC medicines, prescription medications, dietary supplements
Industry3 codes
PRIMARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYAFAKAJAD
Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium)
Agriculture & Food Production/Food Processing & Manufacturing/Specialty & Functional Foods Manufacturing (Organic, Fortified, Medical Foods)
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing32541
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Miscellaneous Food Preparations & Kindred Products2090
Product category
Pharmaceuticals (Biofactor Medicines and Supplements)
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical products
TypeOne Time License
Description

Wörwag Pharma generates revenue through prescription medications (verschreibungspflichtige Präparate), OTC medicines, and dietary supplements. Products are sold across 35+ markets, often as market leaders in their categories

woerwagpharma.de
2Pharmacy and wholesale distribution
TypeTransaction Fee
Description

Products distributed through pharmacies and wholesale channels. Ordering available via PharmaMall online shop, MSV3 electronic interface, telephone, and email

woerwagpharma.de
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Wörwag Pharma Operations
Description

Manufacturing operations site in Łódź, Poland

woerwagpharma.de
+2 more records
Core offering1 text field

Wörwag Pharma develops, manufactures, and sells pharmaceutical products based on biofactors—vitamins, minerals, and trace elements—for the prevention and treatment of lifestyle diseases. The portfolio includes prescription medications, OTC medicines, and dietary supplements focused on diabetic comorbidities, neurological conditions, immune support, and musculoskeletal health, sold across more than 35 markets. Manufacturing is carried out at the company's own production sites in Pöcking, Bavaria and Łódża, Poland.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 8.3% organic revenue growth in 2025, reaching €358.8 million
+4 more records
Product overview1 text field

Wörwag Pharma is a pharmaceutical company specializing in biofactor products (vitamins, minerals, trace elements) and herbal ingredients for over 50 years. The company offers prescription preparations, OTC medicines, and dietary supplements focused on four therapeutic areas: diabetic comorbidities (including diabetic polyneuropathy), nervous system disorders, immune system support, and musculoskeletal health. Core products include B12 Ankermann (vitamin B12), benfotiamine (B1 derivative for diabetic complications), Lagosa Triplex® (new heart-liver-metabolism support), ReDia® (blood sugar management fiber supplement), Zinkorot® 25 (zinc), magnerot® (magnesium), milgamma® protekt (B vitamins for nervous system), Vitagamma®, and Thiogamma® 600 oral. The portfolio spans prescription pharmaceuticals, OTC medications, and dietary supplements available in 35+ markets worldwide, often as market leaders.

Product and service8 records
1B12 Ankermann
CategoryOTC Medicine
Description

Vitamin B12 supplement product addressing vitamin B1 deficiency with high bioavailability. Achieved above-average strong growth in Germany in 2025, expanding its presence in pharmacy and patient markets.

2Lagosa Triplex®
CategoryDietary Supplement
Description

Scientifically formulated nutrient combination supporting the natural function of heart, liver, and lipid metabolism, based on current scientific findings with high bioavailability.

3ReDia®
CategoryDietary Supplement
Description

Innovative dietary fiber supplement with patented formula containing hydroxypropyl methylcellulose (HPMC). Reduces post-meal blood sugar spikes by forming a gel-like consistency in the stomach. Vegan, gluten-free, sugar-free, and lactose-free.

4Benfotiamine
CategoryActive Pharmaceutical Ingredient
Description

Vitamin B1 derivative developed by company founder Dr. Fritz Wörwag into a milestone therapy for diabetic comorbidities, featuring high bioavailability for protecting against vitamin B1 deficiency.

5Zinkorot® 25
CategoryOTC Medicine
Description

Zinc supplement containing 25mg zinc in organic compound with orotic acid. Highest-dose zinc supplement available OTC in German pharmacies. Used for treating zinc deficiency states and supporting immune function.

6milgamma® protekt
CategoryOTC Medicine
Description

Vitamin B product line supporting nervous system health and neurological function.

7Thiogamma® 600 oral
CategoryPrescription Medicine
Description

Prescription alpha-lipoic acid product for diabetic polyneuropathy treatment.

8magnerot® CLASSIC N
CategoryOTC Medicine
Description

Magnesium supplement product for supporting musculoskeletal health and normal bodily functions.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Mauermann Arzneimittel KG (acquired)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-09-01
Description

Acquired contract manufacturer Mauermann Arzneimittel KG in September 2023, renamed to Wörwag Pharma Production GmbH & Co. KG (WPP). Located in Pöcking, Bavaria with approximately 60 employees. Site produces solid oral dosage forms including granulation, drying, coating, and packaging. 45+ years of existing relationship prior to acquisition.

woerwagpharma.de
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-05-01
Description

Acquired Sensilab contract manufacturer in Poland, forming Wörwag Pharma Operations (WPO) in Łódź. Core component of international supply capabilities alongside WPP Pöcking site.

Strategic tierCoreTypeTechnology or Integration
Description

Healthcare professional authentication service enabling secure access to Fachkreise portal with prescription product information. Uses OAuth2 authentication. Compliance with German Heilmittelwerbegesetz (HWG) requirements for medical professional access.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Digital agency responsible for website conception, web design, software development, hosting and ongoing support for www.woerwagpharma.de.

Strategic tierMinorTypeOthers
Description

25+ year CSR partnership supporting education and poverty relief in Tanzania. Projects include vocational schools in Songea, Namtumbo, Zanzibar, and Ndola Zambia. Wörwag family and company support through donations matched euro-for-euro.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

STADA is a major European specialty pharma company (now PE-owned) with broad generics and OTC portfolios including vitamins and biofactor products. Comparable in German heritage and OTC/supplement positioning but operates at substantially larger scale and broader therapeutic scope.

TypeDirect peer
Description

Bionorica is a German family-owned pharmaceutical company specializing in phytopharmaceutical (herbal) medicines for respiratory, urinary, and metabolic conditions. Comparable as a German family-owned specialty pharma with scientifically substantiated natural-ingredient products and strong international presence.

TypeDirect peer
Description

Hermes is a German manufacturer of OTC medicines, dietary supplements, and natural health products including vitamin and mineral formulations. Comparable in size and product category focus with similar OTC/supplement distribution model and German pharma heritage.

4Pharma Stulln GmbH
TypeDirect peer
Description

Pharma Stulln is a German specialty pharmaceutical manufacturer of sterile ophthalmic preparations and selected supplements. Comparable as a German mid-market specialty pharma with focus on specific therapeutic niches and pharmacy distribution.

5Hevert Arzneimittel
TypeDirect peer
Description

Hevert is a German family-owned pharmaceutical company specializing in natural medicine, vitamins, minerals, and homeopathic preparations. Directly comparable to Wörwag in its family-owned structure, German heritage, and focus on micronutrient and natural remedy portfolios across similar therapeutic areas.

TypeBroad incumbent
Description

Dermapharm is a larger German specialty pharmaceutical company with a broad portfolio including branded generics, OTC, and dietary supplements across multiple therapeutic categories. Comparable in its vertically integrated German manufacturing model and portfolio breadth, but operates at a larger scale.

TypeDirect peer
Description

Cesra is a German pharmaceutical company producing homeopathic and natural medicines including herbal and biofactor preparations. Comparable as a smaller German specialty pharma with natural-ingredient focus and pharmacy-channel distribution model.

8Biologische Heilmittel Heel
TypeDirect peer
Description

Heel is a German pharmaceutical company developing biological medicines from natural ingredients for self-medication and complementary therapy. Comparable in its German heritage, scientific substantiation of natural/biofactor products, and focus on lifestyle-related conditions with global distribution.

TypeDirect peer
Description

Mibe is a German specialty pharmaceutical manufacturer offering branded generics and OTC products including vitamin and mineral supplements. Comparable to Wörwag in mid-market German pharma positioning with vertically integrated production and a mixed Rx/OTC/dietary supplement portfolio.

10Steigerwald (Bayer Consumer Health)
TypeBroad incumbent
Description

Steigerwald is a German manufacturer of herbal medicines (notably Iberogast) now part of Bayer Consumer Health. Comparable in its German specialty pharma heritage with scientifically formulated natural/botanical products, though now operates as part of a much larger global consumer health conglomerate.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wörwag Pharma

Pharmaceuticals (Biofactor Medicines and Supplements)woerwagpharma.de

Wörwag Pharma is a family-owned German pharmaceutical company that develops and sells biofactor products (vitamins, minerals, trace elements) for prevention and treatment of lifestyle diseases, with a focus on diabetic comorbidities, nervous system, immune, and musculoskeletal health across 35+ markets.

What Wörwag Pharma does

Wörwag Pharma is a family-owned German pharmaceutical company founded in 1971 in Stuttgart, headquartered in Böblingen, and operating as a GmbH & Co. KG. It specializes in biofactor products — vitamins, minerals, trace elements, and selected herbal actives — for the prevention and treatment of lifestyle-related and metabolic diseases, organized around four therapeutic areas: diabetic comorbidities (notably diabetic polyneuropathy and fatty liver), nervous system health, immune support, and musculoskeletal health. The portfolio spans prescription medicines (e.g., Thiogamma 600 oral, benfotiamine formulations), OTC products (B12 Ankermann, Milgamma, Zinkorot 25, magnerot, Vitagamma), and dietary supplements (ReDia, Lagosa Triplex), with proprietary high-bioavailability formulations such as benfotiamine developed by the founder and the patented ReDia HPMC fiber product. Products are sold in 35+ countries, frequently as category leaders, with deepest historic roots in Central and Eastern Europe and accelerating growth in Asia (Vietnam, Thailand, Philippines, Kazakhstan) and South America (Peru).

The company generates revenue through pharmaceutical product sales distributed via retail pharmacies, pharmacy chains, and pharmaceutical wholesalers, supported by a field sales force that engages doctors and pharmacists, an HCP portal (Fachkreise) with CME-certified content, and a global Health Academy webinar series launched in 2026. Direct pharmacy ordering is enabled through the PharmaMall e-commerce storefront and the MSV3 electronic data interchange, alongside traditional phone/email channels. Wörwag has built vertically integrated manufacturing through the 2021 acquisition of Sensilab (now Wörwag Pharma Operations in Łódź, Poland) and the 2023 acquisition of Mauermann Arzneimittel (now Wörwag Pharma Production in Pöcking, Germany), which together accounted for 42% of packages sold and 33% of the product portfolio from own production in 2025. Family ownership (Wörwag family), a managing-director governance model with Jochen Schlindwein as CEO and Gerhard Mayer as CFO, and a ~1,500-employee workforce across 25+ nationalities support a private, founder-anchored operating model.

Wörwag Pharma firmographics

Firmographics
Name
Wörwag Pharma
Legal name
Wörwag Pharma GmbH & Co. KG
Website
https://woerwagpharma.de
Company type
Private
Founded year
1971
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Wörwag Pharma is a family-owned German pharmaceutical company that develops and sells biofactor products (vitamins, minerals, trace elements) for prevention and treatment of lifestyle diseases, with a focus on diabetic comorbidities, nervous system, immune, and musculoskeletal health across 35+ markets.
Ownership category
akta.pro rank

Wörwag Pharma industry classification

Industry
Product category
Pharmaceuticals (Biofactor Medicines and Supplements)
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Miscellaneous Food Preparations & Kindred Products (2090)
akta.pro industry
PRIMARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYAFAKAJAD
Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium)
Agriculture & Food Production/Food Processing & Manufacturing/Specialty & Functional Foods Manufacturing (Organic, Fortified, Medical Foods)
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences

Keywords

  • Pharmaceutical products
  • Biofactor supplements
  • OTC medicines
  • Prescription medications
  • Dietary supplements

Where Wörwag Pharma is headquartered

Location

Headquarters

HQ city
Böblingen
HQ country
Germany
HQ region
Europe

Offices6 records

Markets served

Wörwag Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical products: Wörwag Pharma generates revenue through prescription medications (verschreibungspflichtige Präparate), OTC medicines, and dietary supplements. Products are sold across 35+ markets, often as market leaders in their categories
  2. Pharmacy and wholesale distribution: Products distributed through pharmacies and wholesale channels. Ordering available via PharmaMall online shop, MSV3 electronic interface, telephone, and email

Go-to-market motion4 records

Distribution channels6 records

Marketing channels8 records

Wörwag Pharma product offering

Product offering

Core offering

Wörwag Pharma develops, manufactures, and sells pharmaceutical products based on biofactors—vitamins, minerals, and trace elements—for the prevention and treatment of lifestyle diseases. The portfolio includes prescription medications, OTC medicines, and dietary supplements focused on diabetic comorbidities, neurological conditions, immune support, and musculoskeletal health, sold across more than 35 markets. Manufacturing is carried out at the company's own production sites in Pöcking, Bavaria and Łódża, Poland.

Product overview

Wörwag Pharma is a pharmaceutical company specializing in biofactor products (vitamins, minerals, trace elements) and herbal ingredients for over 50 years. The company offers prescription preparations, OTC medicines, and dietary supplements focused on four therapeutic areas: diabetic comorbidities (including diabetic polyneuropathy), nervous system disorders, immune system support, and musculoskeletal health. Core products include B12 Ankermann (vitamin B12), benfotiamine (B1 derivative for diabetic complications), Lagosa Triplex® (new heart-liver-metabolism support), ReDia® (blood sugar management fiber supplement), Zinkorot® 25 (zinc), magnerot® (magnesium), milgamma® protekt (B vitamins for nervous system), Vitagamma®, and Thiogamma® 600 oral. The portfolio spans prescription pharmaceuticals, OTC medications, and dietary supplements available in 35+ markets worldwide, often as market leaders.

Differentiator

Problem solved

Functional benefit

Brands

  • Wörwag Pharma Operations: Manufacturing operations site in Łódź, Poland
  • Wörwag Pharma Production
  • Health Academy

Products and services

  • B12 Ankermann Vitamin B12 supplement product addressing vitamin B1 deficiency with high bioavailability. Achieved above-average strong growth in Germany in 2025, expanding its presence in pharmacy and patient markets.
  • Lagosa Triplex® Scientifically formulated nutrient combination supporting the natural function of heart, liver, and lipid metabolism, based on current scientific findings with high bioavailability.
  • ReDia® Innovative dietary fiber supplement with patented formula containing hydroxypropyl methylcellulose (HPMC). Reduces post-meal blood sugar spikes by forming a gel-like consistency in the stomach. Vegan, gluten-free, sugar-free, and lactose-free.
  • Benfotiamine Vitamin B1 derivative developed by company founder Dr. Fritz Wörwag into a milestone therapy for diabetic comorbidities, featuring high bioavailability for protecting against vitamin B1 deficiency.
  • Zinkorot® 25 Zinc supplement containing 25mg zinc in organic compound with orotic acid. Highest-dose zinc supplement available OTC in German pharmacies. Used for treating zinc deficiency states and supporting immune function.
  • milgamma® protekt Vitamin B product line supporting nervous system health and neurological function.
  • Thiogamma® 600 oral Prescription alpha-lipoic acid product for diabetic polyneuropathy treatment.
  • magnerot® CLASSIC N Magnesium supplement product for supporting musculoskeletal health and normal bodily functions.

Quantifiable outcome

  • 8.3% organic revenue growth in 2025, reaching €358.8 million
  • +4 more outcomes

Companies that use Wörwag Pharma

Customer profile

Named customers4 records

Segments6 records

Ideal customer profiles3 records

Wörwag Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature4 records

Wörwag Pharma partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Mauermann Arzneimittel KG (acquired)coreStrategic or Co-development Partner · 1 September 2023Acquired contract manufacturer Mauermann Arzneimittel KG in September 2023, renamed to Wörwag Pharma Production GmbH & Co. KG (WPP). Located in Pöcking, Bavaria with approximately 60 employees. Site produces solid oral dosage forms including granulation, drying, coating, and packaging. 45+ years of existing relationship prior to acquisition.
  • Sensilab (acquired)coreStrategic or Co-development Partner · 1 May 2021Acquired Sensilab contract manufacturer in Poland, forming Wörwag Pharma Operations (WPO) in Łódź. Core component of international supply capabilities alongside WPP Pöcking site.
  • DocCheck Medical Services GmbHcoreTechnology or IntegrationHealthcare professional authentication service enabling secure access to Fachkreise portal with prescription product information. Uses OAuth2 authentication. Compliance with German Heilmittelwerbegesetz (HWG) requirements for medical professional access.
  • TWT Group GmbHminorImplementation/ SI/ Consulting PartnerDigital agency responsible for website conception, web design, software development, hosting and ongoing support for www.woerwagpharma.de.
  • Herrnhuter Missionshilfe e.V.minorOthers25+ year CSR partnership supporting education and poverty relief in Tanzania. Projects include vocational schools in Songea, Namtumbo, Zanzibar, and Ndola Zambia. Wörwag family and company support through donations matched euro-for-euro.

Scale indicators16 records

Recent moves10 records

Expansion highlights6 records

Wörwag Pharma competitors and assessment

Company assessment

Broad incumbents

  • STADA Arzneimittel AG: STADA is a major European specialty pharma company (now PE-owned) with broad generics and OTC portfolios including vitamins and biofactor products. Comparable in German heritage and OTC/supplement positioning but operates at substantially larger scale and broader therapeutic scope.
  • Dermapharm Holding SE: Dermapharm is a larger German specialty pharmaceutical company with a broad portfolio including branded generics, OTC, and dietary supplements across multiple therapeutic categories. Comparable in its vertically integrated German manufacturing model and portfolio breadth, but operates at a larger scale.
  • Steigerwald (Bayer Consumer Health): Steigerwald is a German manufacturer of herbal medicines (notably Iberogast) now part of Bayer Consumer Health. Comparable in its German specialty pharma heritage with scientifically formulated natural/botanical products, though now operates as part of a much larger global consumer health conglomerate.

Direct peers

  • Bionorica SE: Bionorica is a German family-owned pharmaceutical company specializing in phytopharmaceutical (herbal) medicines for respiratory, urinary, and metabolic conditions. Comparable as a German family-owned specialty pharma with scientifically substantiated natural-ingredient products and strong international presence.
  • Hermes Arzneimittel GmbH: Hermes is a German manufacturer of OTC medicines, dietary supplements, and natural health products including vitamin and mineral formulations. Comparable in size and product category focus with similar OTC/supplement distribution model and German pharma heritage.
  • Pharma Stulln GmbH: Pharma Stulln is a German specialty pharmaceutical manufacturer of sterile ophthalmic preparations and selected supplements. Comparable as a German mid-market specialty pharma with focus on specific therapeutic niches and pharmacy distribution.
  • Hevert Arzneimittel: Hevert is a German family-owned pharmaceutical company specializing in natural medicine, vitamins, minerals, and homeopathic preparations. Directly comparable to Wörwag in its family-owned structure, German heritage, and focus on micronutrient and natural remedy portfolios across similar therapeutic areas.
  • Cesra Arzneimittel GmbH: Cesra is a German pharmaceutical company producing homeopathic and natural medicines including herbal and biofactor preparations. Comparable as a smaller German specialty pharma with natural-ingredient focus and pharmacy-channel distribution model.
  • Biologische Heilmittel Heel: Heel is a German pharmaceutical company developing biological medicines from natural ingredients for self-medication and complementary therapy. Comparable in its German heritage, scientific substantiation of natural/biofactor products, and focus on lifestyle-related conditions with global distribution.
  • Mibe GmbH Arzneimittel: Mibe is a German specialty pharmaceutical manufacturer offering branded generics and OTC products including vitamin and mineral supplements. Comparable to Wörwag in mid-market German pharma positioning with vertically integrated production and a mixed Rx/OTC/dietary supplement portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Wörwag Pharma social profiles

Digital presence

Wörwag Pharma compliance and trust

Trust signal

Compliance2 records

Wörwag Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wörwag Pharma leadership team

Management profile

Number of profiles

Profiles6 records

Wörwag Pharma subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Wörwag Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wörwag Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wörwag Pharma

What does Wörwag Pharma do?

Wörwag Pharma develops, manufactures, and sells pharmaceutical products based on biofactors—vitamins, minerals, and trace elements—for the prevention and treatment of lifestyle diseases. The portfolio includes prescription medications, OTC medicines, and dietary supplements focused on diabetic comorbidities, neurological conditions, immune support, and musculoskeletal health, sold across more than 35 markets. Manufacturing is carried out at the company's own production sites in Pöcking, Bavaria and Łódża, Poland.

Is Wörwag Pharma a public or private company?

Wörwag Pharma is a private company. It is classified as family owned and is currently operating.

When was Wörwag Pharma founded?

Wörwag Pharma was founded in 1971. It employs 1,001 to 5,000 people.

Where is Wörwag Pharma based?

Wörwag Pharma is headquartered in Böblingen, Germany, in the Europe region.

How does Wörwag Pharma make money?

Two revenue lines are on record. Pharmaceutical products are the primary driver. The others are pharmacy and wholesale distribution.

Who are Wörwag Pharma's main competitors?

Broad incumbents on record are STADA Arzneimittel AG, Dermapharm Holding SE and Steigerwald (Bayer Consumer Health). Direct peers are Bionorica SE, Hermes Arzneimittel GmbH, Pharma Stulln GmbH, Hevert Arzneimittel, Cesra Arzneimittel GmbH, Biologische Heilmittel Heel and Mibe GmbH Arzneimittel.

Does Wörwag Pharma have an API?

No public API is recorded for Wörwag Pharma.

What industry is Wörwag Pharma in?

Wörwag Pharma's product category is Pharmaceuticals (Biofactor Medicines and Supplements). Its primary akta.pro industry code is HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity), with a secondary code of AFAKAJAD, Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals